Federated Hermes, Inc. Neuronetics, Inc. Transaction History

Federated Hermes, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$2.81 - $6.71 $399 - $952	-142 Reduced 23.39%	465 $1,000
Q4 2022 Feb 13, 2023	SELL	$2.74 - $6.87 $2,013 - $5,049	-735 Reduced 54.77%	607 $4,000
Q3 2022 Nov 14, 2022	SELL	$2.35 - $4.66 $2,382 - $4,725	-1,014 Reduced 43.04%	1,342 $4,000
Q2 2022 Aug 15, 2022	BUY	$2.09 - $3.71 $976 - $1,732	467 Added 24.72%	2,356 $8,000
Q1 2022 May 13, 2022	BUY	$2.84 - $4.52 $5,364 - $8,538	1,889 New	1,889 $6,000
Q2 2021 Aug 16, 2021	SELL	$10.15 - $17.25 $537 - $914	-53 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$10.6 - $21.27 $4,897 - $9,826	-462 Reduced 89.71%	53 $1,000
Q4 2020 Feb 12, 2021	SELL	$4.95 - $11.45 $341 - $790	-69 Reduced 11.82%	515 $6,000
Q3 2020 Nov 12, 2020	SELL	$1.82 - $5.87 $4,036 - $13,019	-2,218 Reduced 79.16%	584 $3,000
Q2 2020 Aug 13, 2020	BUY	$1.41 - $2.61 $2,154 - $3,988	1,528 Added 119.94%	2,802 $5,000
Q1 2020 May 13, 2020	SELL	$1.28 - $4.5 $6,515 - $22,905	-5,090 Reduced 79.98%	1,274 $2,000
Q4 2019 Feb 14, 2020	BUY	$4.03 - $9.22 $25,646 - $58,676	6,364 New	6,364 $29,000

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $40.3M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.